Pancrelipase
From Wikipedia, the free encyclopedia
| Clinical data | |
|---|---|
| AHFS/Drugs.com | monograph |
| MedlinePlus | a604035 |
| Legal status | ? |
| Routes | Oral |
| Identifiers | |
| CAS number | 53608-75-6  |
| ATC code | A09AA02 |
| DrugBank | DB00085 |
| UNII | FQ3DRG0N5K |
| Chemical data | |
| Formula | C5850H8902N1606O1739S49 |
| Mol. mass | 131 kDa |
 (what is this?) (verify) | |
Pancrelipase is a mixture of porcine-derived pancreatic amylase, pancreatic lipase, and chymotrypsin.
Amylase, pancreatic lipase, and chymotrypsin (a kind of protease) are digestive enzymes normally produced by the pancreas.
Pancrelipase is used in the treatment of some digestive disorders, primarily exocrine pancreatic insufficiency, which can result from cystic fibrosis, chronic pancreatitis, and after pancreatectomy.
Pancrelipase is similar to the drug pancreatin, but has an elevated content of lipase.
| ||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.